Mankind Pharma jumped 5.31% to Rs 4,240.75 after the company's consolidated net profit surged 30.43% to Rs 653.47 crore on a 13.6% rise in revenue to Rs 3,076.51 crore in Q2 FY25, compared to Q2 FY24.

A reading above 50 denotes expansion. Manufacturing activity had also increased from a nine-month low of 56.5 to 57.5 in October, which indicated a stronger start to the third quarter buoyed by the ...

A growing number of local companies are going after business in the residential real estate sector, recognising both its investment appeal and the critical need for housing — particularly within the ...

The Rust Belt refers to a part of the country that was once a manufacturing powerhouse but has seen economic decline as ...